教員情報 - 石川　秀明 | 千里金蘭大学

イシカワ　ヒデアキ ishikawa hideaki
石川　秀明

所属千里金蘭大学栄養学部栄養学科

職種教授

学会発表
	国内学会発表（一般演題）　多数（144件）のため省略.
2010/08	The IL-6-mediated signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of human myeloma cells. (14th International Congress of Immunology)
2005/04	Lipid raft translocation of CD45RO, RB but not RA is significant for IL-6 responsive proliferation of myeloma cells. (96th Annual Meeting of American Association for Cancer Research)
2004/12	CD45 defines signaling thresholds critical for proliferation and apoptosis in myeloma cells. (46th Annual Meeting of American Society of Hematology)
2004/12	DHEA can inhibit the proliferation of myeloma cells and the IL-6 production of bone marrow mononuclear cells from the myeloma patients. (46th Annual Meeting of American Society of Hematology)
2004/12	IL-6 induced CD45RO, RB translocation to lipid rafts in myeloma cells. (46th Annual Meeting of American Society of Hematology)
2004/12	Roles of CD19 molecules that suppress proliferation and induce apoptosis in human myeloma cells. (46th Annual Meeting of American Society of Hematology)
2004/07/16	骨髄腫細胞の多様性とシグナル伝達. (第44回日本リンパ網内系学会総会)
2003/12	Biological significance of loss of CD19 molecules in human myeloma cells. (45th Annual Meeting of American Society of Hematology)
2003/12	CD45+ myeloma cells accompanied by VDAC-1 expression are sensitive to apoptosis. (45th Annual Meeting of American Society of Hematology)
2003/12	Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in the IL-6 receptor a highly expressing myeloma cells. (45th Annual Meeting of American Society of Hematology)
2002/12	Consequence of IL-6 receptor a overexpression on IL-6-induced signals in myeloma cells. (44th Annual Meeting of American Society of Hematology)
2002/12	Proliferation of myeloma cells by interleukin-6 co-operated with fibroblast growth factor receptor 3-mediated signals. (44th Annual Meeting of American Society of Hematology)
2001/12	Implication of an inhibitory role of STAT1 for myeloma cell proliferation. (43rd Annual Meeting of American Society of Hematology)
2001/12	Insulin and IGF-1 are survival factors for myeloma cells in vitro. (43rd Annual Meeting of American Society of Hematology)
2001/12	The proliferation of MPC-1-CD49e-CD45+ immature myeloma cells are strictly controlled by IL-6 in the SCID-hIL6 Tg mice. (43rd Annual Meeting of American Society of Hematology)
2000/12	Detection of myeloma cells involved in IgH translocations with several oncogene loci by combined fluorescence-activated cell sorting and fluorescence in situ hybridization. (42nd Annual Meeting of American Society of Hematology)
2000/12	Direct evidence of differentiation pathway from MPC-1- to MPC-1+ myeloma cells by IL-6. (42nd Annual Meeting of American Society of Hematology)
2000/12	Requirement of src family kinase activity associated with CD45 phosphatase for myeloma cell proliferation by interleukin-6. (42nd Annual Meeting of American Society of Hematology)
1999/12	Hypermethylation of the human Pax-5 gene promoter. (41st Annual Meeting of American Society of Hematology)
1999/12	Introduction of CD19 expression leads to growth inhibition and reduced tumorigenicity in human myeloma cell lines. (41st Annual Meeting of American Society of Hematology)
1999/12	The IL-6 responsive and proliferative immature myeloma cells belong to MPC-1-CD45+CD49e- subpopulations. (41st Annual Meeting of American Society of Hematology)
1999/10/14	骨髄腫とPax-5遺伝子およびCD19分子. (第41回日本臨床血液学会総会)
1999/05/27	Isolation of subpopulations of human myeloma cell lines by a cell sorter and their proliferative response to interleukin-6. (Meeting of the International Council of Electrophoresis Societies)
1998/12	Interleukin-6 (IL-6)-induced expression of CD45 antigens and IL-6-responsive growth of a human myeloma cell line, U-266. (40th Annual Meeting of American Society of Hematology)
1998/12	Possible regulatory role of CD19 antigen in human myeloma cell growth. (40th Annual Meeting of American Society of Hematology)
1998/12	The in vivo growth of immature myeloma cell lines in SCID-IL-6 transgenic mice. (40th Annual Meeting of American Society of Hematology)
1998/03/27	形質細胞の腫瘍化とPax-5遺伝子変異. (第60回日本血液学会総会)
1997/12	Myeloma cell lines derived from early plasma cells. (39th Annual Meeting of American Society of Hematology)
1997/12	The expression of Sox-4 and Sox-5 in myeloma cells. (39th Annual Meeting of American Society of Hematology)
1997/07	Loss of Pax-5 expression is possibly involved in growth of human myeloma cells. (10th Symposium on Molecular Biology of Hematopoiesis)
1993/06	Two novel functions associated with the v-Rel oncoprotein: DNA replication and F9 cell-specific transcriptional activation. (9th Annual Meeting on Oncogenes)
1991/12	DNA複製における核内癌遺伝子産物の関与. (第14回日本分子生物学会年会)
1991/07	Possible regulatory mechanism of polyomavirus DNA replication involving protein kinase A and C. (Eukaryotic DNA replication, Cold Spring Harbor Meeting)
1991/06	AP-1 stimulates Py DNA replication and Py early transcription but CREB stimulates only Py early transcription. (Papovaviruses and Adenoviruses, The Imperial Cancer Research Fund Tumor Virus Meeting)
1990/12	Expression of NF-IL6, a transcriptional activator of IL-6 gene, in human blood cells and myeloma cells. (32nd Annual Meeting of American Society of Hematology)
1990/12	IL-6 receptor expression on human myeloma cells. (32nd Annual Meeting of American Society of Hematology)
1990/12	The role of ICAM-1 and LFA-1 molecules expressed on human myeloma cells. (32nd Annual Meeting of American Society of Hematology)
1989/12	Activation of c-myc gene is related to the aggressive transformation of human myeloma cells. (31st Annual Meeting of American Society of Hematology)
1989/09	Production of interleukin 1b, a potent bone resorbing cytokine, by cultured human myeloma cells. (10th International Conference on Calcium Regulating Hormones (American Society for Bone and Mineral Research Meeting))